These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6337581)

  • 21. Hemodialysis and schizophrenia: a double-blind study.
    Malek-Ahmadi P; Sorkin MI; Callen KE; Davis D; Davis LG
    South Med J; 1980 Jul; 73(7):873-4. PubMed ID: 6992283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results.
    Novák T; Horácek J; Mohr P; Kopecek M; Skrdlantová L; Klirova M; Rodriguez M; Spaniel F; Dockery C; Höschl C
    Neuro Endocrinol Lett; 2006; 27(1-2):209-13. PubMed ID: 16648775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind evaluation of plasmapheresis in schizophrenic patients: a pilot study.
    Schulz SC; van Kammen DP; Waters R; Klein HG; Balow JE; Bunney WE
    Artif Organs; 1983 Aug; 7(3):317-21. PubMed ID: 6625960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study.
    Goyal N; Nizamie SH; Desarkar P
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):464-7. PubMed ID: 18070852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experiences with hemofiltration/hemodialysis in schizophrenias].
    Ernst K; Börner I; Herbst A; Klinkmann H; Lindenau K; Osten B; Precht K; Schläfke D; Seidel M
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():114-23. PubMed ID: 6130611
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemodialysis in chronic schizophrenics.
    Schulman A; Wetterberg L; Asaba H; Schulz SC; Van Kammen DP; Meurice E; Nedopil N; Splendiani G
    Arch Gen Psychiatry; 1984 Aug; 41(8):817-9. PubMed ID: 6378119
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of schizophrenia with a vasopressin analogue.
    Iager AC; Kirch DG; Bigelow LB; Karson CN
    Am J Psychiatry; 1986 Mar; 143(3):375-7. PubMed ID: 3513631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dialysis in schizophrenia: successful only in a subtype?
    Reichelt KL
    Schizophr Res; 1996 May; 19(2-3):223-4. PubMed ID: 8789922
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemodialysis in schizophrenia: psychiatric aspects of treatment failure in a pilot study.
    Rorsman B; Franzén G; Sjöstedt L; Lindholm T; Thysell H; Terenius L; Wahlström A
    Neuropsychobiology; 1981; 7(3):127-36. PubMed ID: 6112716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis for schizophrenia: an uncontrolled study of 11 patients.
    Scheiber SC; Cohen I; Yamamura H; Noval R; Beutler L
    Am J Psychiatry; 1981 May; 138(5):662-5. PubMed ID: 7235065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
    Hansbauer M; Wobrock T; Kunze B; Langguth B; Landgrebe M; Eichhammer P; Frank E; Cordes J; Wölwer W; Winterer G; Gaebel W; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Strube W; Schneider-Axmann T; Falkai P; Hasan A
    Psychiatry Res; 2018 May; 263():22-29. PubMed ID: 29482042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo.
    Simopoulos AM; Pinto A; Uhlenhuth EH; McGee JJ; DeRosa ER
    Arch Gen Psychiatry; 1974 Jan; 30(1):106-11. PubMed ID: 4587066
    [No Abstract]   [Full Text] [Related]  

  • 34. A high-dose, double-blind study of ceruletide in the treatment of schizophrenia.
    Mattes JA; Hom W; Rochford JM
    Am J Psychiatry; 1985 Dec; 142(12):1482-4. PubMed ID: 3907376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leicester ECT trial: results in schizophrenia.
    Brandon S; Cowley P; McDonald C; Neville P; Palmer R; Wellstood-Eason S
    Br J Psychiatry; 1985 Feb; 146():177-83. PubMed ID: 3884080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of gluten on schizophrenics.
    Storms LH; Clopton JM; Wright C
    Arch Gen Psychiatry; 1982 Mar; 39(3):323-7. PubMed ID: 7065842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydergine for schizophrenia.
    Cohen MR; Pary R; Burns R
    J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
    [No Abstract]   [Full Text] [Related]  

  • 39. Dialysis treatment in schizophrenia: two years experience.
    Splendiani G; Bruno V; D'Alessandro V; Pomero P; Cammà ML; Tancredi M
    Artif Organs; 1981 May; 5(2):175-7. PubMed ID: 7271531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.